Showing results (21-30 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 2, 2015
Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: a single-centre randomised controlled trialEtheldreda Nakimuli-Mpungu, Kizito Wamala, James Okello, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
The Lancet. HIV|October 2, 2015
Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort studySabin Nsanzimana, Eric Remera, Steve Kanters, et al.
The Lancet. HIV|October 2, 2015
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling studyBohdan Nosyk, Jeong E Min, Viviane D Lima, et al.
The Lancet. HIV|October 2, 2015
Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort studyKeith Ahamad, Kanna Hayashi, Paul Nguyen, et al.
The Lancet. HIV|October 2, 2015
Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort studyJannie J van der Helm, Ronald Geskus, Sara Lodi, et al.
The Lancet. HIV|October 2, 2015
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysisAndrew N Phillips, Valentina Cambiano, Alec Miners, et al.
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
The Lancet. HIV|October 2, 2015
Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort studyElvin H Geng, Thomas A Odeny, Rita E Lyamuya, et al.
The Lancet. HIV|January 15, 2016
Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trialSamir K Gupta, Grace A McComsey, John Lombaard, et al.
Pageof 79